Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Smoldering Multiple Myeloma × Receptors, Interleukin-6 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Smoldering Multiple Myeloma 1 Recurrence 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1

Interventions

Lenalidomide 3 PVX-410 vaccine 2 siltuximab 1 sargramostim 1 poly ICLC 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 citarinostat 1 auricularum 1 atezolizumab 1 Receptors, Interleukin-6 1 Monatide (IMS 3015) 1 Interleukin 1 Receptor Antagonist Protein 1 Emulsions 1 Dexamethasone 1 Calcium Dobesilate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02492750 2020-03-25

Lenalidomide and Dexamethasone With or Without Anakinra in Treating Patients With Early Stage Multiple Myeloma

Mayo Clinic

Phase 1 Completed

14 enrolled 12 charts

Smoldering Multiple Myeloma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡